Title |
Cannabinoids Block Cellular Entry of SARS-CoV-2 and the Emerging Variants
|
---|---|
Published in |
Journal of Natural Products, January 2022
|
DOI | 10.1021/acs.jnatprod.1c00946 |
Pubmed ID | |
Authors |
Richard B. van Breemen, Ruth N. Muchiri, Timothy A. Bates, Jules B. Weinstein, Hans C. Leier, Scotland Farley, Fikadu G. Tafesse |
Abstract |
As a complement to vaccines, small-molecule therapeutic agents are needed to treat or prevent infections by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and its variants, which cause COVID-19. Affinity selection–mass spectrometry was used for the discovery of botanical ligands to the SARS-CoV-2 spike protein. Cannabinoid acids from hemp (Cannabis sativa) were found to be allosteric as well as orthosteric ligands with micromolar affinity for the spike protein. In follow-up virus neutralization assays, cannabigerolic acid and cannabidiolic acid prevented infection of human epithelial cells by a pseudovirus expressing the SARS-CoV-2 spike protein and prevented entry of live SARS-CoV-2 into cells. Importantly, cannabigerolic acid and cannabidiolic acid were equally effective against the SARS-CoV-2 alpha variant B.1.1.7 and the beta variant B.1.351. Orally bioavailable and with a long history of safe human use, these cannabinoids, isolated or in hemp extracts, have the potential to prevent as well as treat infection by SARS-CoV-2. |
Twitter Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 7514 | 28% |
Canada | 574 | 2% |
United Kingdom | 430 | 2% |
Germany | 306 | 1% |
France | 255 | <1% |
Brazil | 222 | <1% |
Australia | 221 | <1% |
Sri Lanka | 213 | <1% |
Comoros | 158 | <1% |
Other | 2311 | 9% |
Unknown | 14729 | 55% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 25918 | 96% |
Scientists | 428 | 2% |
Science communicators (journalists, bloggers, editors) | 326 | 1% |
Practitioners (doctors, other healthcare professionals) | 246 | <1% |
Unknown | 15 | <1% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 237 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 34 | 14% |
Student > Master | 29 | 12% |
Student > Bachelor | 29 | 12% |
Student > Ph. D. Student | 23 | 10% |
Other | 17 | 7% |
Other | 42 | 18% |
Unknown | 63 | 27% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 30 | 13% |
Chemistry | 29 | 12% |
Medicine and Dentistry | 20 | 8% |
Agricultural and Biological Sciences | 18 | 8% |
Pharmacology, Toxicology and Pharmaceutical Science | 16 | 7% |
Other | 52 | 22% |
Unknown | 72 | 30% |